跳至主要内容
临床试验/NCT02374125
NCT02374125Unknown不适用

Effectiveness of Teres Major Muscle Specific Treatment in Patients Diagnosed With Subacromial Impingement Syndrome

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina2 个研究点 分布在 1 个国家目标入组 96 人开始时间: 2014年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
96
试验地点
2
主要终点
Change in Pain intensity (Using a VAS)

研究概览

简要总结

There is not a clear understanding of the origin of symptoms perceived by patients with impingement of the soft tissue structures of the subacromial space. Tendinopathy, tendon rupture or other pathologies, are present in asymptomatic subjects and subjects with symptoms and structural integrity can also be found.

Patients diagnosed with subacromial impingement syndrome frequently have myofascial trigger points in the teres major muscle. Travell and Simons reported that the symptoms caused by trigger points in this muscle are similar to those experienced by patients diagnosed with impingement syndrome, but a literature search provides few results regarding relationship between subacromial impingement syndrome and presence of myofascial trigger points in the teres major muscle.

This study aims to provide evidence of the results that can be obtained with a specific approach of teres mayor muscle by two manual techniques, Trigger Point Pressure Release and Diacutaneous Fibrolysis, in subjects with subacromial impingement syndrome, a condition that still representing both a diagnostic and therapeutic challenge. Secondary objective is to compare the outcomes between both techniques to select for each patient the most appropriate to their needs and characteristics.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years and over
  • Clinical diagnosis of Subacromial Impingement Syndrome.
  • Detectable trigger points in teres major muscle.
  • Sign informed consent form.

排除标准

  • Diacutaneous Fibrolysis contraindications
  • Previous shoulder surgery (<1year)
  • Language barriers or cognitive issues that limit their ability to provide informed consent and participate in research.
  • Patients with a pending litigation or court claim.

研究组 & 干预措施

Control Group

Active Comparator

Protocolized physiotherapy

干预措施: Protocolized physiotherapy (Other)

Fibrolysis Group

Experimental

Actual Diacutaneous Fibrolysis and protocolized physiotherapy

干预措施: Protocolized physiotherapy (Other)

Pressure Group

Experimental

Trigger Point Pressure Release and protocolized physiotherapy

干预措施: Trigger Point Pressure Release (Other)

Pressure Group

Experimental

Trigger Point Pressure Release and protocolized physiotherapy

干预措施: Protocolized physiotherapy (Other)

Fibrolysis Group

Experimental

Actual Diacutaneous Fibrolysis and protocolized physiotherapy

干预措施: Diacutaneous Fibrolysis (Device)

结局指标

主要结局

Change in Pain intensity (Using a VAS)

时间窗: Change from baseline to 3 weeks.

Using a VAS

Change in Functional capacity (Abbreviated Constant-Murley score)

时间窗: Change from baseline to 3 weeks.

Abbreviated Constant-Murley score

次要结局

  • Change in Active Range of Motion(Change from baseline to 3 weeks.)
  • Patient perception of change (Global Rating of Change scale)(3 weeks after recruitment)

研究者

发起方
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验